Tailor-made HIV treatment closer to reality

An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customised for each individual patient, and was developed by Dr J-P. Routy from the Research Institute of the MUHC in collaboration with Dr R. Sekaly from the Universite de Montreal. 'This is a vaccine made for the individual patient - an 'haute couture' therapy, instead of an off-the-rack treatment' said Dr Routy...

Read the whole article on

More from